Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11969421 Bupropion as a modulator of drug activity

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Herriot Tabuteau0

Date of Patent

April 30, 2024

0

Patent Application Number

178412740

Date Filed

June 15, 2022

0

Patent Citations

US Patent 11357744 Bupropion as a modulator of drug activity

0

US Patent 11628149 Bupropion as a modulator of drug activity

0

US Patent 11660273 Dosage forms and methods for enantiomerically enriched or pure bupropion

0

US Patent 11660274 Dosage forms and methods for enantiomerically enriched or pure bupropion

0

US Patent 11752144 Compounds and combinations thereof for treating neurological and psychiatric conditions

0

US Patent 11779579 Bupropion as a modulator of drug activity

0

US Patent 11839612 Compounds and combinations thereof for treating neurological and psychiatric conditions

0

US Patent 11883373 Treatment of depression in certain patient populations

0

...

Patent Citations Received

US Patent 12109178 Bupropion as a modulator of drug activity

0

Patent Primary Examiner

Raymond J. Henley, III

0

CPC Code

0

0

Patent abstract

Disclosed herein are methods of treating neurological or psychiatric diseases or disorders using a combination of bupropion and dextromethorphan. Related compositions and dosage forms are also described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11969421 Bupropion as a modulator of drug activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool